Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases

P. Schochett, R. Mora, L. Mark, M. Butler, Edward P. Ingenito

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of activated leukocytes on surfactant function and composition were examined to better define the mechanisms by which acute inflammation contributes to respiratory distress syndrome (ARDS). Peripheral blood leukocytes from healthy volunteers were incubated in vitro with surfactant for 4 hours: (1) in the absence of activation; (2) following activation by addition of phorbol myristate acetate (PMA); (3) following addition of PMA + FeCl2/EDTA; (4) PMA + FeCl2; (5) PMA + EDTA; (6) PMA + FeCl2 + superoxide dismutase (SOD) + catalase; (7) PMA + EDTA + serine or cysteine protease inhibitors. Surfactant was then repurified by sucrose gradient centrifugation, and function, phospholipid and protein composition, and extent of lipid peroxidation were assessed. PMA caused activation of leukocytes as detected by dichlorofluorescene assay. Lipid peroxidation (assessed by conjugated diene assay) was detected in all samples containing PMA. Abnormal function was noted in surfactant exposed to activated cells with 1 mM EDTA, whereas activation alone, or with FeCl2, had no effect. SOD + catalase prevented lipid peroxidation, but did not prevent leukocyte- mediated dysfunction, which was associated with a marked reduction in surfactant protein A (SP-A), but no detectable change in surfactant protein B (SP-B) or phospholipid composition. Serine protease inhibitors prevented SP-A degradation and dysfunction, whereas cysteine protease inhibitors had no protective effect. Addition of purified SP-A (5% w/w) to dysfunctional surfactant restored normal function, while SP-B/C mixture (3%) did not. Activated leukocytes cause surfactant dysfunction in vitro by serine protease-mediated degradation of SP-A, which occurs only in the presence of EDTA, and is prevented by addition of calcium. Although lipid peroxidation mediated by leukocyte release of free-radical products was also detected, surfactant dysfunction appears to be unrelated to this process.

Original languageEnglish (US)
Pages (from-to)595-616
Number of pages22
JournalExperimental Lung Research
Volume25
Issue number7
DOIs
StatePublished - 1999

Fingerprint

Pulmonary Surfactant-Associated Protein A
Serine Proteases
Tetradecanoylphorbol Acetate
Surface-Active Agents
Neutrophils
Calcium
Degradation
Edetic Acid
Leukocytes
Lipid Peroxidation
Chemical activation
Cysteine Proteinase Inhibitors
Serine Proteinase Inhibitors
Lipids
Catalase
Superoxide Dismutase
Phospholipids
Assays
Chemical analysis
Centrifugation

Keywords

  • Acute lung injury
  • Neutrophils
  • Surfactant dysfunction

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases. / Schochett, P.; Mora, R.; Mark, L.; Butler, M.; Ingenito, Edward P.

In: Experimental Lung Research, Vol. 25, No. 7, 1999, p. 595-616.

Research output: Contribution to journalArticle

Schochett, P. ; Mora, R. ; Mark, L. ; Butler, M. ; Ingenito, Edward P. / Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases. In: Experimental Lung Research. 1999 ; Vol. 25, No. 7. pp. 595-616.
@article{e32d1c0bd40e427f98f96957fbfe1634,
title = "Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases",
abstract = "The effects of activated leukocytes on surfactant function and composition were examined to better define the mechanisms by which acute inflammation contributes to respiratory distress syndrome (ARDS). Peripheral blood leukocytes from healthy volunteers were incubated in vitro with surfactant for 4 hours: (1) in the absence of activation; (2) following activation by addition of phorbol myristate acetate (PMA); (3) following addition of PMA + FeCl2/EDTA; (4) PMA + FeCl2; (5) PMA + EDTA; (6) PMA + FeCl2 + superoxide dismutase (SOD) + catalase; (7) PMA + EDTA + serine or cysteine protease inhibitors. Surfactant was then repurified by sucrose gradient centrifugation, and function, phospholipid and protein composition, and extent of lipid peroxidation were assessed. PMA caused activation of leukocytes as detected by dichlorofluorescene assay. Lipid peroxidation (assessed by conjugated diene assay) was detected in all samples containing PMA. Abnormal function was noted in surfactant exposed to activated cells with 1 mM EDTA, whereas activation alone, or with FeCl2, had no effect. SOD + catalase prevented lipid peroxidation, but did not prevent leukocyte- mediated dysfunction, which was associated with a marked reduction in surfactant protein A (SP-A), but no detectable change in surfactant protein B (SP-B) or phospholipid composition. Serine protease inhibitors prevented SP-A degradation and dysfunction, whereas cysteine protease inhibitors had no protective effect. Addition of purified SP-A (5{\%} w/w) to dysfunctional surfactant restored normal function, while SP-B/C mixture (3{\%}) did not. Activated leukocytes cause surfactant dysfunction in vitro by serine protease-mediated degradation of SP-A, which occurs only in the presence of EDTA, and is prevented by addition of calcium. Although lipid peroxidation mediated by leukocyte release of free-radical products was also detected, surfactant dysfunction appears to be unrelated to this process.",
keywords = "Acute lung injury, Neutrophils, Surfactant dysfunction",
author = "P. Schochett and R. Mora and L. Mark and M. Butler and Ingenito, {Edward P.}",
year = "1999",
doi = "10.1080/019021499270042",
language = "English (US)",
volume = "25",
pages = "595--616",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases

AU - Schochett, P.

AU - Mora, R.

AU - Mark, L.

AU - Butler, M.

AU - Ingenito, Edward P.

PY - 1999

Y1 - 1999

N2 - The effects of activated leukocytes on surfactant function and composition were examined to better define the mechanisms by which acute inflammation contributes to respiratory distress syndrome (ARDS). Peripheral blood leukocytes from healthy volunteers were incubated in vitro with surfactant for 4 hours: (1) in the absence of activation; (2) following activation by addition of phorbol myristate acetate (PMA); (3) following addition of PMA + FeCl2/EDTA; (4) PMA + FeCl2; (5) PMA + EDTA; (6) PMA + FeCl2 + superoxide dismutase (SOD) + catalase; (7) PMA + EDTA + serine or cysteine protease inhibitors. Surfactant was then repurified by sucrose gradient centrifugation, and function, phospholipid and protein composition, and extent of lipid peroxidation were assessed. PMA caused activation of leukocytes as detected by dichlorofluorescene assay. Lipid peroxidation (assessed by conjugated diene assay) was detected in all samples containing PMA. Abnormal function was noted in surfactant exposed to activated cells with 1 mM EDTA, whereas activation alone, or with FeCl2, had no effect. SOD + catalase prevented lipid peroxidation, but did not prevent leukocyte- mediated dysfunction, which was associated with a marked reduction in surfactant protein A (SP-A), but no detectable change in surfactant protein B (SP-B) or phospholipid composition. Serine protease inhibitors prevented SP-A degradation and dysfunction, whereas cysteine protease inhibitors had no protective effect. Addition of purified SP-A (5% w/w) to dysfunctional surfactant restored normal function, while SP-B/C mixture (3%) did not. Activated leukocytes cause surfactant dysfunction in vitro by serine protease-mediated degradation of SP-A, which occurs only in the presence of EDTA, and is prevented by addition of calcium. Although lipid peroxidation mediated by leukocyte release of free-radical products was also detected, surfactant dysfunction appears to be unrelated to this process.

AB - The effects of activated leukocytes on surfactant function and composition were examined to better define the mechanisms by which acute inflammation contributes to respiratory distress syndrome (ARDS). Peripheral blood leukocytes from healthy volunteers were incubated in vitro with surfactant for 4 hours: (1) in the absence of activation; (2) following activation by addition of phorbol myristate acetate (PMA); (3) following addition of PMA + FeCl2/EDTA; (4) PMA + FeCl2; (5) PMA + EDTA; (6) PMA + FeCl2 + superoxide dismutase (SOD) + catalase; (7) PMA + EDTA + serine or cysteine protease inhibitors. Surfactant was then repurified by sucrose gradient centrifugation, and function, phospholipid and protein composition, and extent of lipid peroxidation were assessed. PMA caused activation of leukocytes as detected by dichlorofluorescene assay. Lipid peroxidation (assessed by conjugated diene assay) was detected in all samples containing PMA. Abnormal function was noted in surfactant exposed to activated cells with 1 mM EDTA, whereas activation alone, or with FeCl2, had no effect. SOD + catalase prevented lipid peroxidation, but did not prevent leukocyte- mediated dysfunction, which was associated with a marked reduction in surfactant protein A (SP-A), but no detectable change in surfactant protein B (SP-B) or phospholipid composition. Serine protease inhibitors prevented SP-A degradation and dysfunction, whereas cysteine protease inhibitors had no protective effect. Addition of purified SP-A (5% w/w) to dysfunctional surfactant restored normal function, while SP-B/C mixture (3%) did not. Activated leukocytes cause surfactant dysfunction in vitro by serine protease-mediated degradation of SP-A, which occurs only in the presence of EDTA, and is prevented by addition of calcium. Although lipid peroxidation mediated by leukocyte release of free-radical products was also detected, surfactant dysfunction appears to be unrelated to this process.

KW - Acute lung injury

KW - Neutrophils

KW - Surfactant dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0032703641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032703641&partnerID=8YFLogxK

U2 - 10.1080/019021499270042

DO - 10.1080/019021499270042

M3 - Article

C2 - 10598320

AN - SCOPUS:0032703641

VL - 25

SP - 595

EP - 616

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 7

ER -